1-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-methyl-3-(2-methylpropyl)guanidine;hydroiodide
C15H24IN3O2 — CID 111860610
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-methyl-3-(2-methylpropyl)guanidine;hydroiodide
1-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-methyl-3-(2-methylpropyl)guanidine;hydroiodide (PubChem CID 111860610) has the molecular formula C15H24IN3O2 and a molecular weight of 405.28 g/mol. Its IUPAC name is 1-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-methyl-3-(2-methylpropyl)guanidine;hydroiodide.
Molecular Properties
| Compound Name | 1-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-methyl-3-(2-methylpropyl)guanidine;hydroiodide |
|---|---|
| PubChem CID | 111860610 |
| Molecular Formula | C15H24IN3O2 |
| Molecular Weight | 405.28 g/mol |
| Exact Mass | 405.09 |
| IUPAC Name | 1-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-methyl-3-(2-methylpropyl)guanidine;hydroiodide |
| SMILES | C/N=C(\NCC(C)C)Nc1ccc2c(c1)OCCCO2.I |
| InChI | InChI=1S/C15H23N3O2.HI/c1-11(2)10-17-15(16-3)18-12-5-6-13-14(9-12)20-8-4-7-19-13;/h5-6,9,11H,4,7-8,10H2,1-3H3,(H2,16,17,18);1H |
| InChIKey | FKSGEBGQBATPLY-UHFFFAOYSA-N |
| XLogP | 3.11 |
| TPSA | 54.88 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 405.28 |
| LogP ≤ 5 | 3.11 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 111860610 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.